All 5 Conference Bundles
Get the Complete Experience: Purchase all five conference bundles and save- learn more, spend less
Maximize your learning and stay ahead in your field by accessing the highest rated sessions from Anticoagulation Forum’s 2025 National Conference. This all-inclusive program offers the best value for those who want to take full advantage of our expert-led presentations, in-depth discussions, and audience Q&As—without missing a single moment. Whether you're looking to deepen your knowledge, gain practical insights, or revisit key takeaways on your own schedule, this comprehensive package ensures you won't miss any of the groundbreaking content from this year's meeting.
Clinical decision-making isn’t always black and white—this session dives into the complex and often controversial topics that fall into the "gray zone" of anticoagulation management. Dr. Jean Connors will explore the nuances of thrombophilia testing, examining when it’s helpful, when it’s not, and how to interpret results in a clinical context. Drs. Ana Casanegra and Shruti Chaturvedi will address the diagnostic and therapeutic challenges of antiphospholipid syndrome (APS), offering insights into risk stratification and evolving treatment strategies. Drs. Gabe Fontaine and Deb Siegal will tackle the rapidly evolving landscape of DOAC reversal, including emerging agents and clinical application.
Sound decision-making starts with asking the right questions. This session focuses on how to avoid common errors in anticoagulation management through thoughtful assessment and evidence-based practice. Dr. Karina Meijer provides an examination into the nuances of coagulation testing: who needs it, when it’s appropriate, and how to choose the right tests for the right scenarios. Dr. Snehal Bhatt provides practical discussion on weighing the risks and benefits of anticoagulation—when to initiate, when to hold off, and how to navigate those borderline cases. Finally, Dr. Arthur Allen shares common mistakes seen in clinical practice, and offers tips on how to recognize and avoid them.
Optimal anticoagulation management often requires input from across specialties—this session highlights how collaboration enhances care in complex clinical situations. Dr. Minhaj Khaja offers the interventional radiologist’s perspective, focusing on procedural considerations and anticoagulation around interventions. Dr. Thalia Field (previously recorded) shares the vascular neurologist’s approach to stroke prevention and treatment in anticoagulated patients. Dr. Jeff Federspiel concludes the session with insights from an obstetrician on managing anticoagulation in pregnancy, from conception through delivery. Together, these expert voices demonstrate how interdisciplinary teamwork leads to better patient outcomes.
When thrombotic and bleeding risks collide, management becomes anything but straightforward. Dr. Jori May opens with a discussion on concomitant arterial and venous thrombosis—how to approach diagnosis, assess risk, and choose an anticoagulation strategy that addresses both pathways. Dr. Anita Rajasekhar delves into the nuances of liver coagulopathy, highlighting the dual threat of bleeding and thrombosis and how to individualize care. Finally, Dr. Ming Lim addresses the challenging case of the “bleeding patient who clots,” providing insight into evaluation, treatment options, and additional considerations.
Innovation continues to reshape the landscape of anticoagulation care—this session highlights emerging strategies, therapies, and care models that are moving the field forward. Andrea Van Beek discusses how anticoagulation clinics can stay relevant in an era of simplified therapies and decentralized care, offering practical approaches to evolve and thrive. Dr. Youssef Bessada presents novel VTE care models that emphasize outpatient management, care coordination, and improved patient outcomes. Dr. Geoff Barnes provides an inside look at new anticoagulants in development, focusing on Factor XI and XII inhibitors and their potential to change risk profiles in thrombotic disease. Dr. Behnood Bikdeli wraps up with a deep dive into the ongoing complexities of valve management.
This package of conference bundles is accredited for a total of 7.25 continuing education credits. Please view all individual learner notifications on each bundle page. The CE evaluations will become available on June 9.
Please note that the below sessions are on-demand accredited sessions.
